Ava Announces Launch of First Clinical Trial Evaluating Effectiveness of Its Fertility Tracking Sensor Bracelet in Real-time, Pre-Symptomatic Detection of COVID-19
Data analysis from earlier COVI-GAPP pilot study shows Ava’s algorithm accurately detected 71% of COVID-19 positive infections two days prior to symptom onset. ZURICH — March 23, 2021 — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind to test whether